GO:0005198 | structural molecule activity | 13.28% (32/241) | 4.8 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 27.8% (67/241) | 2.59 | 0.0 | 0.0 |
GO:0044391 | ribosomal subunit | 9.96% (24/241) | 5.51 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 54.36% (131/241) | 1.44 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 10.37% (25/241) | 5.16 | 0.0 | 0.0 |
GO:0005840 | ribosome | 9.96% (24/241) | 5.33 | 0.0 | 0.0 |
GO:0015934 | large ribosomal subunit | 7.88% (19/241) | 5.9 | 0.0 | 0.0 |
GO:0006412 | translation | 9.96% (24/241) | 4.92 | 0.0 | 0.0 |
GO:0022625 | cytosolic large ribosomal subunit | 7.47% (18/241) | 6.11 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 10.79% (26/241) | 4.52 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 9.96% (24/241) | 4.8 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 11.2% (27/241) | 4.15 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 9.96% (24/241) | 4.54 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 14.11% (34/241) | 3.48 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 12.03% (29/241) | 3.81 | 0.0 | 0.0 |
GO:0043226 | organelle | 30.71% (74/241) | 1.91 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 30.71% (74/241) | 1.91 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 14.11% (34/241) | 3.21 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 44.4% (107/241) | 1.33 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 18.67% (45/241) | 2.51 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 18.67% (45/241) | 2.44 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 34.85% (84/241) | 1.53 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 17.43% (42/241) | 2.53 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 12.03% (29/241) | 3.28 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 27.8% (67/241) | 1.75 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 31.95% (77/241) | 1.55 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 38.59% (93/241) | 1.34 | 0.0 | 0.0 |
GO:0008150 | biological_process | 54.77% (132/241) | 0.98 | 0.0 | 0.0 |
GO:0009987 | cellular process | 42.32% (102/241) | 1.2 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 39.0% (94/241) | 1.28 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 36.51% (88/241) | 1.34 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 23.24% (56/241) | 1.84 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 10.79% (26/241) | 3.11 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.79% (26/241) | 3.11 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 20.75% (50/241) | 1.96 | 0.0 | 0.0 |
GO:0065003 | protein-containing complex assembly | 7.47% (18/241) | 3.79 | 0.0 | 0.0 |
GO:0005634 | nucleus | 15.35% (37/241) | 2.05 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 29.05% (70/241) | 1.31 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 7.47% (18/241) | 3.21 | 0.0 | 0.0 |
GO:0070180 | large ribosomal subunit rRNA binding | 2.07% (5/241) | 8.15 | 0.0 | 0.0 |
GO:0000786 | nucleosome | 2.9% (7/241) | 6.17 | 0.0 | 0.0 |
GO:0043933 | protein-containing complex organization | 7.47% (18/241) | 3.05 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 56.43% (136/241) | 0.67 | 0.0 | 0.0 |
GO:0043231 | intracellular membrane-bounded organelle | 19.92% (48/241) | 1.51 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 19.92% (48/241) | 1.49 | 0.0 | 0.0 |
GO:0022618 | protein-RNA complex assembly | 4.15% (10/241) | 4.41 | 0.0 | 0.0 |
GO:0031492 | nucleosomal DNA binding | 2.07% (5/241) | 7.58 | 0.0 | 0.0 |
GO:0071826 | protein-RNA complex organization | 4.15% (10/241) | 4.37 | 0.0 | 0.0 |
GO:0045910 | negative regulation of DNA recombination | 2.07% (5/241) | 7.01 | 0.0 | 0.0 |
GO:0006334 | nucleosome assembly | 2.49% (6/241) | 5.99 | 0.0 | 0.0 |
GO:0000018 | regulation of DNA recombination | 2.07% (5/241) | 6.74 | 0.0 | 0.0 |
GO:0034728 | nucleosome organization | 2.49% (6/241) | 5.61 | 0.0 | 0.0 |
GO:0030527 | structural constituent of chromatin | 2.07% (5/241) | 6.07 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 7.88% (19/241) | 2.27 | 0.0 | 0.0 |
GO:0009057 | macromolecule catabolic process | 5.81% (14/241) | 2.68 | 0.0 | 1e-06 |
GO:0051053 | negative regulation of DNA metabolic process | 2.07% (5/241) | 5.68 | 0.0 | 1e-06 |
GO:0002181 | cytoplasmic translation | 2.07% (5/241) | 5.57 | 0.0 | 2e-06 |
GO:0030261 | chromosome condensation | 2.07% (5/241) | 5.54 | 0.0 | 2e-06 |
GO:0140513 | nuclear protein-containing complex | 7.05% (17/241) | 2.24 | 0.0 | 3e-06 |
GO:0003676 | nucleic acid binding | 16.18% (39/241) | 1.3 | 0.0 | 3e-06 |
GO:0031491 | nucleosome binding | 2.07% (5/241) | 5.29 | 0.0 | 4e-06 |
GO:1901575 | organic substance catabolic process | 7.47% (18/241) | 2.11 | 0.0 | 4e-06 |
GO:0065004 | protein-DNA complex assembly | 2.49% (6/241) | 4.42 | 0.0 | 7e-06 |
GO:0051603 | proteolysis involved in protein catabolic process | 4.56% (11/241) | 2.85 | 1e-06 | 8e-06 |
GO:0009056 | catabolic process | 7.47% (18/241) | 2.04 | 1e-06 | 8e-06 |
GO:0022627 | cytosolic small ribosomal subunit | 2.07% (5/241) | 5.0 | 1e-06 | 9e-06 |
GO:0071840 | cellular component organization or biogenesis | 9.54% (23/241) | 1.69 | 1e-06 | 1.4e-05 |
GO:0005737 | cytoplasm | 9.96% (24/241) | 1.63 | 1e-06 | 1.8e-05 |
GO:0005488 | binding | 36.1% (87/241) | 0.68 | 1e-06 | 1.8e-05 |
GO:0019843 | rRNA binding | 2.07% (5/241) | 4.65 | 2e-06 | 2.8e-05 |
GO:0032993 | protein-DNA complex | 2.9% (7/241) | 3.62 | 2e-06 | 2.8e-05 |
GO:0044613 | nuclear pore central transport channel | 1.24% (3/241) | 6.96 | 2e-06 | 2.8e-05 |
GO:0003723 | RNA binding | 7.88% (19/241) | 1.84 | 2e-06 | 2.9e-05 |
GO:0016043 | cellular component organization | 8.71% (21/241) | 1.72 | 2e-06 | 3e-05 |
GO:0019899 | enzyme binding | 3.32% (8/241) | 3.27 | 2e-06 | 3e-05 |
GO:0015935 | small ribosomal subunit | 2.07% (5/241) | 4.57 | 3e-06 | 3.3e-05 |
GO:0031490 | chromatin DNA binding | 2.07% (5/241) | 4.56 | 3e-06 | 3.5e-05 |
GO:1901565 | organonitrogen compound catabolic process | 4.56% (11/241) | 2.57 | 3e-06 | 4.1e-05 |
GO:0051052 | regulation of DNA metabolic process | 2.07% (5/241) | 4.39 | 5e-06 | 6e-05 |
GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex | 0.83% (2/241) | 8.82 | 9e-06 | 0.000103 |
GO:0044877 | protein-containing complex binding | 4.15% (10/241) | 2.5 | 1.4e-05 | 0.000167 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.73% (9/241) | 2.65 | 1.8e-05 | 0.000204 |
GO:0031324 | negative regulation of cellular metabolic process | 3.73% (9/241) | 2.62 | 2e-05 | 0.000228 |
GO:0003682 | chromatin binding | 2.9% (7/241) | 3.11 | 2.1e-05 | 0.00023 |
GO:0009892 | negative regulation of metabolic process | 3.73% (9/241) | 2.62 | 2.1e-05 | 0.000232 |
GO:0005080 | protein kinase C binding | 0.83% (2/241) | 8.2 | 2.2e-05 | 0.000237 |
GO:0019941 | modification-dependent protein catabolic process | 3.32% (8/241) | 2.73 | 3.5e-05 | 0.000373 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 2.9% (7/241) | 2.97 | 3.9e-05 | 0.000412 |
GO:0050794 | regulation of cellular process | 11.62% (28/241) | 1.2 | 3.9e-05 | 0.000416 |
GO:0000028 | ribosomal small subunit assembly | 1.24% (3/241) | 5.51 | 4.4e-05 | 0.000457 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.32% (8/241) | 2.67 | 4.6e-05 | 0.000476 |
GO:0006508 | proteolysis | 5.39% (13/241) | 1.93 | 4.9e-05 | 0.000502 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.15% (10/241) | 2.28 | 5.3e-05 | 0.000535 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 2.49% (6/241) | 3.21 | 5.5e-05 | 0.000545 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.07% (5/241) | 3.66 | 5.5e-05 | 0.000547 |
GO:0034655 | nucleobase-containing compound catabolic process | 2.9% (7/241) | 2.85 | 6.5e-05 | 0.000633 |
GO:0071013 | catalytic step 2 spliceosome | 1.66% (4/241) | 4.24 | 6.9e-05 | 0.000662 |
GO:0070647 | protein modification by small protein conjugation or removal | 4.15% (10/241) | 2.22 | 7.4e-05 | 0.000712 |
GO:0006338 | chromatin remodeling | 2.49% (6/241) | 3.13 | 7.7e-05 | 0.000731 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.79% (26/241) | 1.2 | 8e-05 | 0.000754 |
GO:0097159 | organic cyclic compound binding | 23.65% (57/241) | 0.72 | 8.3e-05 | 0.000773 |
GO:0043687 | post-translational protein modification | 4.56% (11/241) | 2.05 | 8.8e-05 | 0.000812 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.83% (2/241) | 7.15 | 9.4e-05 | 0.000828 |
GO:0030132 | clathrin coat of coated pit | 0.83% (2/241) | 7.15 | 9.4e-05 | 0.000828 |
GO:0060255 | regulation of macromolecule metabolic process | 8.71% (21/241) | 1.36 | 9.2e-05 | 0.00083 |
GO:0050789 | regulation of biological process | 11.62% (28/241) | 1.13 | 9.1e-05 | 0.000832 |
GO:1901360 | organic cyclic compound metabolic process | 11.62% (28/241) | 1.13 | 9.3e-05 | 0.000833 |
GO:0046483 | heterocycle metabolic process | 11.2% (27/241) | 1.15 | 9.7e-05 | 0.000846 |
GO:0031323 | regulation of cellular metabolic process | 8.71% (21/241) | 1.35 | 0.0001 | 0.000861 |
GO:0046700 | heterocycle catabolic process | 2.9% (7/241) | 2.72 | 0.00011 | 0.000933 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.9% (7/241) | 2.72 | 0.00011 | 0.000933 |
GO:0006325 | chromatin organization | 2.49% (6/241) | 3.0 | 0.000123 | 0.00103 |
GO:0065007 | biological regulation | 12.03% (29/241) | 1.08 | 0.000126 | 0.001044 |
GO:0006725 | cellular aromatic compound metabolic process | 11.2% (27/241) | 1.12 | 0.000141 | 0.001163 |
GO:0032774 | RNA biosynthetic process | 2.9% (7/241) | 2.66 | 0.000147 | 0.001197 |
GO:0048523 | negative regulation of cellular process | 3.73% (9/241) | 2.24 | 0.000149 | 0.001201 |
GO:0019222 | regulation of metabolic process | 8.71% (21/241) | 1.3 | 0.000154 | 0.001234 |
GO:0010498 | proteasomal protein catabolic process | 2.49% (6/241) | 2.93 | 0.000158 | 0.001259 |
GO:0048519 | negative regulation of biological process | 3.73% (9/241) | 2.22 | 0.000169 | 0.001335 |
GO:0031325 | positive regulation of cellular metabolic process | 2.9% (7/241) | 2.61 | 0.000181 | 0.001413 |
GO:0045544 | gibberellin 20-oxidase activity | 0.83% (2/241) | 6.56 | 0.000218 | 0.001688 |
GO:0071004 | U2-type prespliceosome | 1.24% (3/241) | 4.71 | 0.000226 | 0.00171 |
GO:0071010 | prespliceosome | 1.24% (3/241) | 4.71 | 0.000226 | 0.00171 |
GO:0019439 | aromatic compound catabolic process | 2.9% (7/241) | 2.55 | 0.000226 | 0.001737 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.66% (4/241) | 3.77 | 0.000236 | 0.001769 |
GO:0006090 | pyruvate metabolic process | 2.07% (5/241) | 3.2 | 0.000243 | 0.00181 |
GO:1901361 | organic cyclic compound catabolic process | 2.9% (7/241) | 2.53 | 0.000251 | 0.001837 |
GO:0030163 | protein catabolic process | 2.49% (6/241) | 2.81 | 0.00025 | 0.001846 |
GO:0019900 | kinase binding | 1.24% (3/241) | 4.64 | 0.00026 | 0.00189 |
GO:0003677 | DNA binding | 7.47% (18/241) | 1.34 | 0.000331 | 0.002373 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.56% (11/241) | 1.83 | 0.000329 | 0.002376 |
GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity | 0.83% (2/241) | 6.2 | 0.000359 | 0.002529 |
GO:0004738 | pyruvate dehydrogenase activity | 0.83% (2/241) | 6.2 | 0.000359 | 0.002529 |
GO:0048522 | positive regulation of cellular process | 2.9% (7/241) | 2.43 | 0.000375 | 0.002627 |
GO:0018130 | heterocycle biosynthetic process | 4.15% (10/241) | 1.92 | 0.00039 | 0.002713 |
GO:0070279 | vitamin B6 binding | 1.66% (4/241) | 3.57 | 0.000398 | 0.002724 |
GO:0030170 | pyridoxal phosphate binding | 1.66% (4/241) | 3.57 | 0.000398 | 0.002724 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.9% (7/241) | 2.41 | 0.000412 | 0.002763 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.66% (4/241) | 3.56 | 0.00041 | 0.00277 |
GO:0071824 | protein-DNA complex organization | 2.49% (6/241) | 2.68 | 0.000408 | 0.002773 |
GO:0005665 | RNA polymerase II, core complex | 1.24% (3/241) | 4.4 | 0.000421 | 0.0028 |
GO:0009893 | positive regulation of metabolic process | 2.9% (7/241) | 2.39 | 0.000448 | 0.002936 |
GO:0010604 | positive regulation of macromolecule metabolic process | 2.9% (7/241) | 2.39 | 0.000446 | 0.002947 |
GO:1990234 | transferase complex | 3.73% (9/241) | 2.01 | 0.000481 | 0.003134 |
GO:0009416 | response to light stimulus | 1.66% (4/241) | 3.49 | 0.000488 | 0.003156 |
GO:0009791 | post-embryonic development | 1.24% (3/241) | 4.32 | 0.000494 | 0.003172 |
GO:0006414 | translational elongation | 1.24% (3/241) | 4.31 | 0.000509 | 0.003249 |
GO:0019438 | aromatic compound biosynthetic process | 4.15% (10/241) | 1.84 | 0.000574 | 0.003641 |
GO:0090567 | reproductive shoot system development | 0.83% (2/241) | 5.82 | 0.000599 | 0.003748 |
GO:0009908 | flower development | 0.83% (2/241) | 5.82 | 0.000599 | 0.003748 |
GO:0098797 | plasma membrane protein complex | 1.24% (3/241) | 4.21 | 0.000617 | 0.003834 |
GO:0030125 | clathrin vesicle coat | 0.83% (2/241) | 5.78 | 0.000641 | 0.003852 |
GO:0016255 | attachment of GPI anchor to protein | 0.83% (2/241) | 5.78 | 0.000641 | 0.003852 |
GO:0042765 | GPI-anchor transamidase complex | 0.83% (2/241) | 5.78 | 0.000641 | 0.003852 |
GO:0030118 | clathrin coat | 0.83% (2/241) | 5.78 | 0.000641 | 0.003852 |
GO:0008303 | caspase complex | 0.83% (2/241) | 5.78 | 0.000641 | 0.003852 |
GO:0009314 | response to radiation | 1.66% (4/241) | 3.38 | 0.000652 | 0.003897 |
GO:0051171 | regulation of nitrogen compound metabolic process | 7.05% (17/241) | 1.29 | 0.000746 | 0.004426 |
GO:0016593 | Cdc73/Paf1 complex | 0.83% (2/241) | 5.64 | 0.000773 | 0.004557 |
GO:0000245 | spliceosomal complex assembly | 0.83% (2/241) | 5.63 | 0.000788 | 0.004619 |
GO:0030880 | RNA polymerase complex | 1.66% (4/241) | 3.29 | 0.000817 | 0.004758 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 2.07% (5/241) | 2.81 | 0.000828 | 0.004763 |
GO:0072344 | rescue of stalled ribosome | 0.83% (2/241) | 5.58 | 0.000835 | 0.004776 |
GO:0080090 | regulation of primary metabolic process | 7.05% (17/241) | 1.27 | 0.000826 | 0.004783 |
GO:0019693 | ribose phosphate metabolic process | 2.49% (6/241) | 2.46 | 0.000888 | 0.005049 |
GO:0019842 | vitamin binding | 1.66% (4/241) | 3.25 | 0.000906 | 0.005087 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.49% (6/241) | 2.45 | 0.000905 | 0.005113 |
GO:0030955 | potassium ion binding | 0.83% (2/241) | 5.49 | 0.00095 | 0.005242 |
GO:0004743 | pyruvate kinase activity | 0.83% (2/241) | 5.49 | 0.00095 | 0.005242 |
GO:0031420 | alkali metal ion binding | 0.83% (2/241) | 5.49 | 0.00095 | 0.005242 |
GO:0060560 | developmental growth involved in morphogenesis | 0.83% (2/241) | 5.45 | 0.001002 | 0.005462 |
GO:0009826 | unidimensional cell growth | 0.83% (2/241) | 5.45 | 0.001002 | 0.005462 |
GO:0051276 | chromosome organization | 2.49% (6/241) | 2.42 | 0.001024 | 0.005519 |
GO:0097602 | cullin family protein binding | 0.83% (2/241) | 5.44 | 0.001019 | 0.005525 |
GO:0036211 | protein modification process | 9.96% (24/241) | 1.0 | 0.001037 | 0.005557 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 1.66% (4/241) | 3.19 | 0.001068 | 0.005658 |
GO:0048518 | positive regulation of biological process | 2.9% (7/241) | 2.17 | 0.001076 | 0.005668 |
GO:0045182 | translation regulator activity | 1.66% (4/241) | 3.19 | 0.001064 | 0.005671 |
GO:0070646 | protein modification by small protein removal | 1.66% (4/241) | 3.18 | 0.001093 | 0.005727 |
GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 0.83% (2/241) | 5.38 | 0.001108 | 0.005776 |
GO:0018193 | peptidyl-amino acid modification | 2.49% (6/241) | 2.39 | 0.001134 | 0.005878 |
GO:0005684 | U2-type spliceosomal complex | 1.24% (3/241) | 3.9 | 0.001145 | 0.005903 |
GO:0031369 | translation initiation factor binding | 0.83% (2/241) | 5.31 | 0.001221 | 0.006156 |
GO:0009686 | gibberellin biosynthetic process | 0.83% (2/241) | 5.31 | 0.001221 | 0.006156 |
GO:0005515 | protein binding | 13.28% (32/241) | 0.83 | 0.001211 | 0.006176 |
GO:0006351 | DNA-templated transcription | 2.07% (5/241) | 2.68 | 0.001209 | 0.006199 |
GO:0006163 | purine nucleotide metabolic process | 2.49% (6/241) | 2.34 | 0.001331 | 0.006677 |
GO:0005689 | U12-type spliceosomal complex | 0.83% (2/241) | 5.23 | 0.001358 | 0.006776 |
GO:0048589 | developmental growth | 0.83% (2/241) | 5.22 | 0.001378 | 0.00684 |
GO:1905369 | endopeptidase complex | 0.83% (2/241) | 5.19 | 0.00144 | 0.007071 |
GO:1901135 | carbohydrate derivative metabolic process | 3.32% (8/241) | 1.92 | 0.001433 | 0.007075 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.9% (7/241) | 2.09 | 0.001479 | 0.007225 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.24% (3/241) | 3.73 | 0.001589 | 0.007644 |
GO:0051641 | cellular localization | 4.15% (10/241) | 1.65 | 0.001584 | 0.007658 |
GO:0008446 | GDP-mannose 4,6-dehydratase activity | 0.41% (1/241) | 9.28 | 0.001603 | 0.007673 |
GO:0097525 | spliceosomal snRNP complex | 1.24% (3/241) | 3.74 | 0.001581 | 0.007684 |
GO:0140535 | intracellular protein-containing complex | 3.32% (8/241) | 1.89 | 0.001648 | 0.007808 |
GO:1901136 | carbohydrate derivative catabolic process | 1.66% (4/241) | 3.02 | 0.001645 | 0.007834 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 0.83% (2/241) | 5.06 | 0.001699 | 0.008007 |
GO:0032790 | ribosome disassembly | 0.83% (2/241) | 5.06 | 0.001721 | 0.008072 |
GO:0016049 | cell growth | 0.83% (2/241) | 5.03 | 0.00179 | 0.008351 |
GO:0072521 | purine-containing compound metabolic process | 2.49% (6/241) | 2.25 | 0.001817 | 0.008438 |
GO:0005686 | U2 snRNP | 0.83% (2/241) | 4.93 | 0.002051 | 0.009477 |
GO:0120114 | Sm-like protein family complex | 1.24% (3/241) | 3.6 | 0.00207 | 0.009518 |
GO:0061631 | ubiquitin conjugating enzyme activity | 0.83% (2/241) | 4.89 | 0.00215 | 0.009839 |
GO:0019901 | protein kinase binding | 0.83% (2/241) | 4.87 | 0.002201 | 0.010021 |
GO:0003690 | double-stranded DNA binding | 2.9% (7/241) | 1.98 | 0.00223 | 0.010104 |
GO:0051254 | positive regulation of RNA metabolic process | 2.07% (5/241) | 2.47 | 0.002281 | 0.010239 |
GO:0040007 | growth | 0.83% (2/241) | 4.85 | 0.002278 | 0.010271 |
GO:0030159 | signaling receptor complex adaptor activity | 0.41% (1/241) | 8.7 | 0.002404 | 0.010636 |
GO:0010387 | COP9 signalosome assembly | 0.41% (1/241) | 8.7 | 0.002404 | 0.010636 |
GO:0009150 | purine ribonucleotide metabolic process | 2.07% (5/241) | 2.46 | 0.002383 | 0.010645 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.24% (3/241) | 3.52 | 0.002418 | 0.01065 |
GO:0043022 | ribosome binding | 1.24% (3/241) | 3.51 | 0.00246 | 0.010784 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.07% (5/241) | 2.43 | 0.002563 | 0.011028 |
GO:0009891 | positive regulation of biosynthetic process | 2.07% (5/241) | 2.43 | 0.002563 | 0.011028 |
GO:0031328 | positive regulation of cellular biosynthetic process | 2.07% (5/241) | 2.43 | 0.002563 | 0.011028 |
GO:0016070 | RNA metabolic process | 5.81% (14/241) | 1.26 | 0.002537 | 0.011069 |
GO:0005829 | cytosol | 4.15% (10/241) | 1.55 | 0.002588 | 0.011086 |
GO:0140096 | catalytic activity, acting on a protein | 10.37% (25/241) | 0.88 | 0.002625 | 0.011194 |
GO:0010562 | positive regulation of phosphorus metabolic process | 0.83% (2/241) | 4.69 | 0.002821 | 0.011557 |
GO:0042327 | positive regulation of phosphorylation | 0.83% (2/241) | 4.69 | 0.002821 | 0.011557 |
GO:0045937 | positive regulation of phosphate metabolic process | 0.83% (2/241) | 4.69 | 0.002821 | 0.011557 |
GO:0035591 | signaling adaptor activity | 0.41% (1/241) | 8.48 | 0.002804 | 0.011638 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 0.41% (1/241) | 8.48 | 0.002804 | 0.011638 |
GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 0.41% (1/241) | 8.48 | 0.002804 | 0.011638 |
GO:0045948 | positive regulation of translational initiation | 0.41% (1/241) | 8.48 | 0.002804 | 0.011638 |
GO:0001934 | positive regulation of protein phosphorylation | 0.83% (2/241) | 4.71 | 0.002765 | 0.011681 |
GO:0061650 | ubiquitin-like protein conjugating enzyme activity | 0.83% (2/241) | 4.71 | 0.002765 | 0.011681 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 2.07% (5/241) | 2.39 | 0.002884 | 0.011764 |
GO:0009685 | gibberellin metabolic process | 0.83% (2/241) | 4.65 | 0.002995 | 0.012163 |
GO:0000993 | RNA polymerase II complex binding | 0.83% (2/241) | 4.64 | 0.003025 | 0.01223 |
GO:0019752 | carboxylic acid metabolic process | 4.15% (10/241) | 1.51 | 0.003102 | 0.012488 |
GO:0004795 | threonine synthase activity | 0.41% (1/241) | 8.28 | 0.003204 | 0.012574 |
GO:0000389 | mRNA 3'-splice site recognition | 0.41% (1/241) | 8.28 | 0.003204 | 0.012574 |
GO:0006082 | organic acid metabolic process | 4.15% (10/241) | 1.51 | 0.003182 | 0.012596 |
GO:0009117 | nucleotide metabolic process | 2.49% (6/241) | 2.09 | 0.003144 | 0.012603 |
GO:0048367 | shoot system development | 0.83% (2/241) | 4.6 | 0.003174 | 0.012616 |
GO:0043436 | oxoacid metabolic process | 4.15% (10/241) | 1.51 | 0.003165 | 0.012632 |
GO:0006753 | nucleoside phosphate metabolic process | 2.49% (6/241) | 2.08 | 0.003304 | 0.012912 |
GO:0005681 | spliceosomal complex | 1.66% (4/241) | 2.73 | 0.003368 | 0.013107 |
GO:0048608 | reproductive structure development | 0.83% (2/241) | 4.56 | 0.003389 | 0.013136 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 0.83% (2/241) | 4.52 | 0.003546 | 0.013689 |
GO:0016102 | diterpenoid biosynthetic process | 0.83% (2/241) | 4.5 | 0.003675 | 0.014069 |
GO:0044248 | cellular catabolic process | 3.32% (8/241) | 1.7 | 0.003661 | 0.014074 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 0.83% (2/241) | 4.47 | 0.003805 | 0.01451 |
GO:0033565 | ESCRT-0 complex | 0.41% (1/241) | 7.96 | 0.004003 | 0.015081 |
GO:0019774 | proteasome core complex, beta-subunit complex | 0.41% (1/241) | 7.96 | 0.004003 | 0.015081 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5.81% (14/241) | 1.19 | 0.003978 | 0.015108 |
GO:0090304 | nucleic acid metabolic process | 7.88% (19/241) | 0.98 | 0.00409 | 0.015347 |
GO:0048731 | system development | 0.83% (2/241) | 4.4 | 0.004175 | 0.015603 |
GO:0009259 | ribonucleotide metabolic process | 2.07% (5/241) | 2.25 | 0.004319 | 0.016013 |
GO:0097526 | spliceosomal tri-snRNP complex | 0.83% (2/241) | 4.38 | 0.004314 | 0.016057 |
GO:0033290 | eukaryotic 48S preinitiation complex | 0.41% (1/241) | 7.82 | 0.004403 | 0.016259 |
GO:0043175 | RNA polymerase core enzyme binding | 0.83% (2/241) | 4.35 | 0.00449 | 0.016515 |
GO:0006085 | acetyl-CoA biosynthetic process | 0.83% (2/241) | 4.33 | 0.004597 | 0.016844 |
GO:0000902 | cell morphogenesis | 0.83% (2/241) | 4.3 | 0.004815 | 0.017371 |
GO:0009756 | carbohydrate mediated signaling | 0.41% (1/241) | 7.7 | 0.004802 | 0.017391 |
GO:0010182 | sugar mediated signaling pathway | 0.41% (1/241) | 7.7 | 0.004802 | 0.017391 |
GO:0042802 | identical protein binding | 0.83% (2/241) | 4.3 | 0.004778 | 0.01744 |
GO:0009134 | nucleoside diphosphate catabolic process | 1.24% (3/241) | 3.13 | 0.005095 | 0.017635 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.24% (3/241) | 3.13 | 0.005095 | 0.017635 |
GO:0071616 | acyl-CoA biosynthetic process | 0.83% (2/241) | 4.28 | 0.004926 | 0.017635 |
GO:0035384 | thioester biosynthetic process | 0.83% (2/241) | 4.28 | 0.004926 | 0.017635 |
GO:0043021 | ribonucleoprotein complex binding | 1.24% (3/241) | 3.13 | 0.005128 | 0.017684 |
GO:0046031 | ADP metabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0009137 | purine nucleoside diphosphate catabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0046032 | ADP catabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0006096 | glycolytic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.24% (3/241) | 3.14 | 0.005078 | 0.017708 |
GO:0019364 | pyridine nucleotide catabolic process | 1.24% (3/241) | 3.12 | 0.005228 | 0.017831 |
GO:0008234 | cysteine-type peptidase activity | 1.66% (4/241) | 2.55 | 0.005194 | 0.017846 |
GO:0043412 | macromolecule modification | 9.96% (24/241) | 0.82 | 0.005214 | 0.017849 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 0.83% (2/241) | 4.22 | 0.005303 | 0.018024 |
GO:0072526 | pyridine-containing compound catabolic process | 1.24% (3/241) | 3.11 | 0.005379 | 0.018217 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.24% (3/241) | 3.08 | 0.005621 | 0.018966 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 0.83% (2/241) | 4.17 | 0.005694 | 0.019143 |
GO:0070063 | RNA polymerase binding | 0.83% (2/241) | 4.15 | 0.005814 | 0.019475 |
GO:0141047 | molecular tag activity | 0.83% (2/241) | 4.12 | 0.006097 | 0.020138 |
GO:0031386 | protein tag activity | 0.83% (2/241) | 4.12 | 0.006097 | 0.020138 |
GO:0009261 | ribonucleotide catabolic process | 1.24% (3/241) | 3.04 | 0.006068 | 0.020184 |
GO:0009154 | purine ribonucleotide catabolic process | 1.24% (3/241) | 3.04 | 0.00605 | 0.020195 |
GO:0042273 | ribosomal large subunit biogenesis | 0.83% (2/241) | 4.1 | 0.006221 | 0.020473 |
GO:0016101 | diterpenoid metabolic process | 0.83% (2/241) | 4.08 | 0.006387 | 0.020947 |
GO:0006195 | purine nucleotide catabolic process | 1.24% (3/241) | 3.01 | 0.006479 | 0.021175 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.24% (3/241) | 3.0 | 0.006555 | 0.02135 |
GO:0009132 | nucleoside diphosphate metabolic process | 1.24% (3/241) | 2.99 | 0.006651 | 0.021588 |
GO:0004660 | protein farnesyltransferase activity | 0.41% (1/241) | 7.2 | 0.006796 | 0.021757 |
GO:0005965 | protein farnesyltransferase complex | 0.41% (1/241) | 7.2 | 0.006796 | 0.021757 |
GO:0018343 | protein farnesylation | 0.41% (1/241) | 7.2 | 0.006796 | 0.021757 |
GO:0019637 | organophosphate metabolic process | 3.32% (8/241) | 1.55 | 0.006821 | 0.021763 |
GO:0009628 | response to abiotic stimulus | 1.66% (4/241) | 2.43 | 0.006862 | 0.021819 |
GO:0009166 | nucleotide catabolic process | 1.24% (3/241) | 2.99 | 0.006749 | 0.021828 |
GO:1901292 | nucleoside phosphate catabolic process | 1.24% (3/241) | 2.96 | 0.007125 | 0.022579 |
GO:0051247 | positive regulation of protein metabolic process | 1.24% (3/241) | 2.94 | 0.007431 | 0.022929 |
GO:0031401 | positive regulation of protein modification process | 0.83% (2/241) | 3.98 | 0.007382 | 0.02293 |
GO:0000027 | ribosomal large subunit assembly | 0.83% (2/241) | 3.98 | 0.007382 | 0.02293 |
GO:0098796 | membrane protein complex | 2.49% (6/241) | 1.83 | 0.007411 | 0.022944 |
GO:0045893 | positive regulation of DNA-templated transcription | 1.66% (4/241) | 2.4 | 0.007345 | 0.022965 |
GO:1902680 | positive regulation of RNA biosynthetic process | 1.66% (4/241) | 2.4 | 0.007345 | 0.022965 |
GO:0018105 | peptidyl-serine phosphorylation | 1.24% (3/241) | 2.93 | 0.007535 | 0.023097 |
GO:0018209 | peptidyl-serine modification | 1.24% (3/241) | 2.93 | 0.007535 | 0.023097 |
GO:0001098 | basal transcription machinery binding | 0.83% (2/241) | 3.98 | 0.007338 | 0.023097 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 0.83% (2/241) | 3.98 | 0.007338 | 0.023097 |
GO:0044272 | sulfur compound biosynthetic process | 1.24% (3/241) | 2.92 | 0.007639 | 0.023341 |
GO:0000247 | C-8 sterol isomerase activity | 0.41% (1/241) | 6.96 | 0.007991 | 0.023644 |
GO:0004769 | steroid delta-isomerase activity | 0.41% (1/241) | 6.96 | 0.007991 | 0.023644 |
GO:0047750 | cholestenol delta-isomerase activity | 0.41% (1/241) | 6.96 | 0.007991 | 0.023644 |
GO:0070993 | translation preinitiation complex | 0.41% (1/241) | 6.96 | 0.007991 | 0.023644 |
GO:0071821 | FANCM-MHF complex | 0.41% (1/241) | 6.96 | 0.007991 | 0.023644 |
GO:0009653 | anatomical structure morphogenesis | 0.83% (2/241) | 3.91 | 0.00802 | 0.023658 |
GO:0070727 | cellular macromolecule localization | 2.9% (7/241) | 1.64 | 0.008084 | 0.02377 |
GO:0006996 | organelle organization | 3.73% (9/241) | 1.4 | 0.007873 | 0.023899 |
GO:0046907 | intracellular transport | 2.9% (7/241) | 1.64 | 0.00785 | 0.023906 |
GO:0006084 | acetyl-CoA metabolic process | 0.83% (2/241) | 3.92 | 0.007928 | 0.023911 |
GO:0033036 | macromolecule localization | 2.9% (7/241) | 1.63 | 0.008166 | 0.023936 |
GO:0032446 | protein modification by small protein conjugation | 2.49% (6/241) | 1.81 | 0.007923 | 0.023972 |
GO:0008104 | protein localization | 2.9% (7/241) | 1.64 | 0.007988 | 0.024016 |
GO:0019783 | ubiquitin-like protein peptidase activity | 1.24% (3/241) | 2.88 | 0.008241 | 0.02408 |
GO:0004662 | CAAX-protein geranylgeranyltransferase activity | 0.41% (1/241) | 6.89 | 0.008388 | 0.02436 |
GO:0005953 | CAAX-protein geranylgeranyltransferase complex | 0.41% (1/241) | 6.89 | 0.008388 | 0.02436 |
GO:0006898 | receptor-mediated endocytosis | 0.83% (2/241) | 3.87 | 0.008539 | 0.02472 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 0.83% (2/241) | 3.85 | 0.008682 | 0.025059 |
GO:0006446 | regulation of translational initiation | 0.41% (1/241) | 6.82 | 0.008786 | 0.025203 |
GO:1990726 | Lsm1-7-Pat1 complex | 0.41% (1/241) | 6.82 | 0.008786 | 0.025203 |
GO:0072523 | purine-containing compound catabolic process | 1.24% (3/241) | 2.84 | 0.008823 | 0.025232 |
GO:0030276 | clathrin binding | 0.83% (2/241) | 3.82 | 0.009071 | 0.025863 |
GO:0051649 | establishment of localization in cell | 2.9% (7/241) | 1.59 | 0.009342 | 0.026553 |
GO:1905368 | peptidase complex | 0.83% (2/241) | 3.75 | 0.009923 | 0.028036 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 0.83% (2/241) | 3.75 | 0.009923 | 0.028036 |
GO:0046034 | ATP metabolic process | 1.24% (3/241) | 2.77 | 0.010084 | 0.028404 |
GO:0006402 | mRNA catabolic process | 1.24% (3/241) | 2.77 | 0.010133 | 0.028458 |
GO:0033866 | nucleoside bisphosphate biosynthetic process | 0.83% (2/241) | 3.72 | 0.010388 | 0.028828 |
GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 0.83% (2/241) | 3.72 | 0.010388 | 0.028828 |
GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 0.83% (2/241) | 3.72 | 0.010388 | 0.028828 |
GO:0002182 | cytoplasmic translational elongation | 0.41% (1/241) | 6.58 | 0.010375 | 0.029051 |
GO:0000287 | magnesium ion binding | 1.24% (3/241) | 2.74 | 0.010738 | 0.029713 |
GO:0008023 | transcription elongation factor complex | 0.83% (2/241) | 3.68 | 0.010969 | 0.030261 |
GO:1903008 | organelle disassembly | 0.83% (2/241) | 3.67 | 0.011076 | 0.030467 |
GO:0006164 | purine nucleotide biosynthetic process | 1.24% (3/241) | 2.7 | 0.011604 | 0.031826 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.24% (3/241) | 2.69 | 0.011685 | 0.031954 |
GO:0005688 | U6 snRNP | 0.41% (1/241) | 6.38 | 0.011962 | 0.032428 |
GO:0098799 | outer mitochondrial membrane protein complex | 0.41% (1/241) | 6.38 | 0.011962 | 0.032428 |
GO:0005742 | mitochondrial outer membrane translocase complex | 0.41% (1/241) | 6.38 | 0.011962 | 0.032428 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.24% (3/241) | 2.68 | 0.012065 | 0.032614 |
GO:0051246 | regulation of protein metabolic process | 1.66% (4/241) | 2.17 | 0.012701 | 0.034235 |
GO:0032784 | regulation of DNA-templated transcription elongation | 0.83% (2/241) | 3.56 | 0.012738 | 0.034236 |
GO:0004830 | tryptophan-tRNA ligase activity | 0.41% (1/241) | 6.24 | 0.01315 | 0.035042 |
GO:0071020 | post-spliceosomal complex | 0.41% (1/241) | 6.24 | 0.01315 | 0.035042 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 0.41% (1/241) | 6.24 | 0.01315 | 0.035042 |
GO:0005654 | nucleoplasm | 0.83% (2/241) | 3.53 | 0.013256 | 0.035225 |
GO:0044281 | small molecule metabolic process | 4.98% (12/241) | 1.07 | 0.013476 | 0.035709 |
GO:0000350 | generation of catalytic spliceosome for second transesterification step | 0.41% (1/241) | 6.2 | 0.013546 | 0.035792 |
GO:0016071 | mRNA metabolic process | 2.07% (5/241) | 1.85 | 0.013598 | 0.035827 |
GO:0004430 | 1-phosphatidylinositol 4-kinase activity | 0.41% (1/241) | 6.15 | 0.013942 | 0.036427 |
GO:0031510 | SUMO activating enzyme complex | 0.41% (1/241) | 6.15 | 0.013942 | 0.036427 |
GO:0019948 | SUMO activating enzyme activity | 0.41% (1/241) | 6.15 | 0.013942 | 0.036427 |
GO:0031625 | ubiquitin protein ligase binding | 0.83% (2/241) | 3.49 | 0.014081 | 0.036689 |
GO:0072522 | purine-containing compound biosynthetic process | 1.24% (3/241) | 2.59 | 0.014224 | 0.036756 |
GO:0010857 | calcium-dependent protein kinase activity | 0.83% (2/241) | 3.48 | 0.014201 | 0.036796 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 0.83% (2/241) | 3.48 | 0.014201 | 0.036796 |
GO:0004683 | calmodulin-dependent protein kinase activity | 0.83% (2/241) | 3.47 | 0.014441 | 0.037214 |
GO:0044389 | ubiquitin-like protein ligase binding | 0.83% (2/241) | 3.45 | 0.014744 | 0.037891 |
GO:0009070 | serine family amino acid biosynthetic process | 0.83% (2/241) | 3.42 | 0.015359 | 0.039148 |
GO:0032787 | monocarboxylic acid metabolic process | 2.07% (5/241) | 1.8 | 0.015285 | 0.039174 |
GO:0046390 | ribose phosphate biosynthetic process | 1.24% (3/241) | 2.54 | 0.015334 | 0.039191 |
GO:0032051 | clathrin light chain binding | 0.41% (1/241) | 6.0 | 0.015523 | 0.039352 |
GO:0071439 | clathrin complex | 0.41% (1/241) | 6.0 | 0.015523 | 0.039352 |
GO:0032501 | multicellular organismal process | 1.24% (3/241) | 2.53 | 0.01581 | 0.039972 |
GO:0006401 | RNA catabolic process | 1.24% (3/241) | 2.53 | 0.015874 | 0.040026 |
GO:0009299 | mRNA transcription | 0.41% (1/241) | 5.96 | 0.015918 | 0.040028 |
GO:0051382 | kinetochore assembly | 0.41% (1/241) | 5.89 | 0.016707 | 0.041567 |
GO:0019264 | glycine biosynthetic process from serine | 0.41% (1/241) | 5.89 | 0.016707 | 0.041567 |
GO:0070905 | serine binding | 0.41% (1/241) | 5.89 | 0.016707 | 0.041567 |
GO:0004372 | glycine hydroxymethyltransferase activity | 0.41% (1/241) | 5.89 | 0.016707 | 0.041567 |
GO:0050815 | phosphoserine residue binding | 0.41% (1/241) | 5.86 | 0.017101 | 0.041992 |
GO:0071618 | lysophosphatidylethanolamine acyltransferase activity | 0.41% (1/241) | 5.86 | 0.017101 | 0.041992 |
GO:0051383 | kinetochore organization | 0.41% (1/241) | 5.86 | 0.017101 | 0.041992 |
GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding | 0.41% (1/241) | 5.86 | 0.017101 | 0.041992 |
GO:0099122 | RNA polymerase II C-terminal domain binding | 0.41% (1/241) | 5.86 | 0.017101 | 0.041992 |
GO:0046391 | 5-phosphoribose 1-diphosphate metabolic process | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0004749 | ribose phosphate diphosphokinase activity | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0002189 | ribose phosphate diphosphokinase complex | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0051219 | phosphoprotein binding | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0045309 | protein phosphorylated amino acid binding | 0.41% (1/241) | 5.82 | 0.017495 | 0.042078 |
GO:0003006 | developmental process involved in reproduction | 0.83% (2/241) | 3.32 | 0.017397 | 0.042606 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.24% (3/241) | 2.47 | 0.01749 | 0.042724 |
GO:0010629 | negative regulation of gene expression | 1.66% (4/241) | 2.01 | 0.01812 | 0.043468 |
GO:0000338 | protein deneddylation | 0.41% (1/241) | 5.76 | 0.018283 | 0.043749 |
GO:0004197 | cysteine-type endopeptidase activity | 0.83% (2/241) | 3.28 | 0.018389 | 0.043892 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.24% (3/241) | 2.43 | 0.018911 | 0.045022 |
GO:0006637 | acyl-CoA metabolic process | 0.83% (2/241) | 3.25 | 0.019133 | 0.045319 |
GO:0035383 | thioester metabolic process | 0.83% (2/241) | 3.25 | 0.019133 | 0.045319 |
GO:0005794 | Golgi apparatus | 1.66% (4/241) | 1.98 | 0.01956 | 0.046215 |
GO:0016860 | intramolecular oxidoreductase activity | 0.83% (2/241) | 3.23 | 0.019612 | 0.046221 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 0.83% (2/241) | 3.23 | 0.01975 | 0.046429 |
GO:0006565 | L-serine catabolic process | 0.41% (1/241) | 5.64 | 0.019857 | 0.046565 |
GO:0000932 | P-body | 0.83% (2/241) | 3.22 | 0.020026 | 0.046845 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 0.41% (1/241) | 5.61 | 0.02025 | 0.047017 |
GO:0004661 | protein geranylgeranyltransferase activity | 0.41% (1/241) | 5.61 | 0.02025 | 0.047017 |
GO:0046434 | organophosphate catabolic process | 1.24% (3/241) | 2.39 | 0.020173 | 0.047071 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.24% (3/241) | 2.37 | 0.020877 | 0.048352 |
GO:0019362 | pyridine nucleotide metabolic process | 1.24% (3/241) | 2.37 | 0.021102 | 0.048634 |
GO:0009069 | serine family amino acid metabolic process | 0.83% (2/241) | 3.18 | 0.02108 | 0.048701 |
GO:1903311 | regulation of mRNA metabolic process | 0.83% (2/241) | 3.17 | 0.021293 | 0.048953 |
GO:0044843 | cell cycle G1/S phase transition | 0.41% (1/241) | 5.5 | 0.021821 | 0.049923 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.41% (1/241) | 5.5 | 0.021821 | 0.049923 |